Benitec Biopharma Inc.
BNTC | NASDAQ
$10.95
+$0.07 (+0.64%)
At close: Sep 22, 2026, 4:00 PM ET
$10.95
$0 (0.00%)
After-hours:
Sep 22, 2026, 4:54 PM ET
TTM Period Ending | Q4 2026 Jun 29, 2026 | Q3 2026 Mar 30, 2026 | Q2 2026 Dec 30, 2025 | Q1 2026 Sep 29, 2025 | Q4 2025 Jun 29, 2025 | Q3 2025 Mar 30, 2025 | Q2 2025 Dec 30, 2024 | Q1 2025 Sep 29, 2024 | Q4 2024 Jun 29, 2024 | Q3 2024 Mar 30, 2024 | Q2 2024 Dec 30, 2023 | Q1 2024 Sep 29, 2023 | Q4 2023 Jun 29, 2023 | Q3 2023 Mar 30, 2023 | Q2 2023 Dec 30, 2022 | Q1 2023 Sep 29, 2022 | Q4 2022 Jun 29, 2022 | Q3 2022 Mar 30, 2022 | Q2 2022 Dec 30, 2021 | Q1 2022 Sep 29, 2021 | Q4 2021 Jun 29, 2021 | Q3 2021 Mar 30, 2021 | Q2 2021 Dec 30, 2020 | Q1 2021 Sep 29, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | 556K | 556K | 556K | 556K | -6K | -6K | -6K | -6K | 7K | 61K | 75K | 75K | 68K | 62K | 73K | 73K | 75K | 28K | 4K | 59K | 17K | 62.11K | 170.43K |
Cost of Revenue | 481K | 635K | 622K | 583K | 556K | 293K | 184K | 104K | -93K | -24K | -21K | 19K | 227K | 152K | 152K | 111K | 111K | 103K | 110K | 91K | 123K | 170K | 240.4K | -175.07K |
Gross Profit | -481K | -79K | -66K | -27K | n/a | -299K | -190K | -110K | 87K | 115K | 166K | 181K | -27K | -43K | -49K | -38K | -38K | -28K | -82K | -87K | -64K | -153K | -178.29K | 345.5K |
Operating Income | -51.19M | -46.6M | -48.35M | -45.78M | -41.77M | -37.48M | -26.29M | -22.41M | -22.49M | -21.49M | -21.69M | -20.38M | -19.08M | -19.27M | -18.39M | -17.61M | -17.86M | -16.97M | -17.31M | -15.73M | -13.6M | -12.63M | -12.31M | -12.05M |
Interest Income | 3.17M | 1.59M | 823K | 1.65M | 1.65M | 2.57M | 1.74M | 920K | 920K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -15.1K | 11.25K | 35.38K |
Pretax Income | -45.55M | -41.54M | -44.11M | -41.82M | -37.92M | -33.83M | -23.61M | -20.86M | -21.75M | -21.69M | -21.81M | -20.42M | -19.56M | -19.97M | -18.85M | -18.26M | -18.21M | -17.14M | -17.78M | -16.21M | -13.88M | -12.81M | -12.37M | -12.08M |
Net Income | -45.55M | -48.88M | -51.45M | -49.17M | -45.26M | -33.83M | -23.61M | -20.86M | -21.75M | -21.69M | -21.81M | -20.42M | -19.56M | -19.97M | -18.85M | -18.26M | -18.21M | -17.14M | -17.78M | -16.21M | -13.88M | -12.81M | -12.37M | -12.08M |
Selling & General & Admin | 27.8M | 34.74M | 36.3M | 34.17M | 29.95M | 18.5M | 11.24M | 7.64M | 6.99M | 6.32M | 5.97M | 6.01M | 6.38M | 6.56M | 6.67M | 6.52M | 6.65M | 6.63M | 6.32M | 6.72M | 6.51M | 6.88M | 7.97M | 8.54M |
Research & Development | 25.12M | 19.2M | 19.39M | 18.95M | 19.16M | 18.98M | 15.05M | 14.77M | 15.61M | 15.28M | 15.88M | 14.54M | 12.77M | 12.76M | 11.77M | 11.15M | 11.27M | 10.42M | 11M | 9.03M | 7.02M | 5.61M | 4.17M | 3.86M |
Other Expenses | -2.25M | -7.85M | -7.84M | -7.8M | -7.74M | -278K | -172K | -91K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5K | -5K | -5K |
Operating Expenses | 50.68M | 46.09M | 47.85M | 45.32M | 41.37M | 37.2M | 26.12M | 22.32M | 22.6M | 21.61M | 21.86M | 20.56M | 19.16M | 19.33M | 18.44M | 17.68M | 17.92M | 17.05M | 17.33M | 15.74M | 13.53M | 12.48M | 12.13M | 12.4M |
Interest Expense | -2.4M | -3.44M | -3.44M | -2.05M | -1.64M | -604K | -600K | -594K | 16K | 24K | 27K | 30K | 33K | 35K | 38K | 40K | 32K | 23K | 15K | 6K | 6K | 5K | 3K | 1K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 51.19M | 46.6M | 48.35M | 45.78M | 41.77M | 37.48M | 26.29M | 22.41M | 22.49M | 21.5M | 21.75M | 20.45M | 19.16M | 19.34M | 18.45M | 17.69M | 17.93M | 17.05M | 17.33M | 15.73M | 13.66M | 12.65M | 12.37M | 12.22M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 46.56M | 49.39M | 45.97M | 41.52M | 36.21M | 38.6M | 22.08M | 10.64M | 10.09M | 10.44M | 10.3M | 8.63M | 6.58M | 1.65M | 6.48M | 2.55M | 1.92M | 1.92M | 1.92M | 1.92M | 1.66M | 1.12M | 1.01M | 260.79K |
Shares Outstanding (Diluted) | 46.56M | 49.39M | 45.97M | 41.52M | 36.21M | 38.6M | 22.08M | 10.64M | 10.09M | 10.47M | 10.31M | 8.63M | 6.58M | 1.65M | 6.49M | 2.55M | 1.92M | 1.92M | 1.92M | 1.92M | 1.66M | 1.12M | 1.01M | 260.79K |
EPS (Basic) | -0.98 | -1.10 | -1.24 | -1.31 | -1.58 | -1.72 | -1.57 | -1.78 | -1.90 | -2.78 | -5.22 | -4.88 | -4.75 | -8.61 | -6.34 | -6.73 | -6.88 | -6.43 | -6.85 | -7.02 | -15.42 | -30.65 | -45.19 | -60.13 |
EPS (Diluted) | -0.98 | -1.10 | -1.24 | -1.31 | -1.58 | -1.72 | -1.57 | -1.78 | -1.90 | -2.78 | -5.22 | -4.88 | -4.75 | -8.61 | -6.34 | -6.73 | -6.88 | -6.43 | -13.03 | -13.20 | -21.60 | -39.48 | -59.96 | -93.20 |
EBITDA | -50.71M | -53.46M | -55.23M | -52.7M | -48.71M | -37.04M | -25.86M | -21.85M | -21.94M | -21.12M | -21.37M | -19.96M | -19.15M | -19.57M | -18.43M | -17.82M | -17.78M | -16.54M | -17.18M | -15.62M | -13.28M | -12.33M | -11.85M | -11.64M |
EBIT | -51.19M | -53.94M | -55.69M | -53.12M | -49.11M | -37.41M | -26.21M | -22.2M | -22.28M | -21.46M | -21.71M | -20.32M | -19.53M | -19.93M | -18.81M | -18.22M | -18.18M | -16.97M | -17.62M | -16.06M | -13.7M | -12.73M | -12.3M | -12.05M |
Depreciation & Amortization | 481K | 475K | 462K | 423K | 396K | 369K | 353K | 352K | 343K | 336K | 339K | 361K | 381K | 360K | 381K | 392K | 392K | 431K | 432K | 434K | 424K | 408K | 449.44K | 406.85K |
Add to Watchlist
Select watchlists to add or remove BNTC